Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 1-9 of 9
  • previous
  • 1
  • next
Item hits:
Issue DateTitleAuthor(s)
13-Jul-2016Aurora-A Kinase: A Potent Oncogene and Target for Cancer TherapyYan, M; Wang, C; He, B; Yang, M; Tong, M, et al
12-Sep-2017p62/SQSTM1 interacts with vimentin to enhance breast cancer metastasisLam, EW; Yao, S; Dallman, M; Bugeon; Bella, L, et al
12-Aug-201611a-N-Tosyl-5-deoxi-pterocarpan, LQB-223, a novel compound with potent antineoplastic activity toward breast cancer cells with different phenotypes.Lemos, LG; Nestal de Moraes, G; Delbue, D; Vasconcelos, FD; Bernardo, PS, et al
29-Sep-2016FOXO3a and the MAPK p38 are activated by cetuximab to induce cell death and inhibit cell proliferation and their expression predicts cetuximab efficacy in colorectal cancer.Marzi, L; Combes, E; ViƩ, N; Ayrolles-Torro, A; Tosi, D, et al
15-Aug-2016RNF168 cooperates with RNF8 to mediate FOXM1 ubiquitination and degradation in breast cancer epirubicin treatmentLam, EW; Kongsema, M; Zona, S; Karunarathna, U; Yao, S, et al
8-Mar-2017Dataset of the human homologues and orthologues of lipid-metabolic genes identified as DAF-16 targets and their roles in lipid and energy metabolismFan, LY; Saavedra Garcia, P; Lam, EW; Medical Research Council (MRC); Imperial College Trust
13-Mar-2018SUMOylation modulates FOXK2-mediated paclitaxel sensitivity in breast cancer cellsNestal de Moraes, G; Ji, Z; Lavender, F; Yao, S; Zona, S, et al
4-Apr-2016BRCA1 positively regulates FOXO3 expression by restricting FOXO3 gene methylation and epigenetic silencing through targeting EZH2 in breast cancerLam, EW; Gong, C; Yao, S; Gomes, AR; Cancer Research UK, et al
1-Jun-2018The FOXO3-FOXM1 Axis: a key cancer drug target and a modulator of cancer drug resistanceYao, S; Fan, YN; Lam, EW; Biotechnology and Biological Sciences Research Council (BBSRC); Imperial College Trust, et al